Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Orphenadrine hydrochloride
Cat. No.:
OB0225LY-0174
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Orphenadrine hydrochloride is a muscarinic antagonist with analgesic and muscle relaxant.
Synonym:
Mebedrol; Mephenamin; 341-69-5; Orphenadrine HCl; Mephenamin; Mephenamine; Mebedrol; Mephenamin forte; 2-Dimethylaminoethyl 2-methylbenzhydryl ether hydrochloride; N, N-Dimethyl-2-(2-methylbenzhydryloxy)ethylamine hydrochloride; Ethanamine, N, N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, hydrochloride; beta-Dimethylaminoethyl 2-methylbenzhydryl ether hydrochloride
CAS No.:
341-69-5
Compound CID:
9568
Formula:
C18H23NO·HCl
Formula Weight:
305.85
Specification
Relative Density:
1.014 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Orphenadrine hydrochloride can be used for muscle spasm and pain management research.
Library Information
Targets:
G protein-coupled receptors (GPCRs); Monoamine transporters
Receptors:
H1 receptor; iGluR; NMDA receptor; Noradrenaline transporter (Sodium-dependent); Sodium channel
Pathways:
GPCR/G protein; Membrane transporter/Ion channel; Immunology/Inflammation; Neuronal signaling
Plate Number:
AOCL-3
Plate Location:
b7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 147.13 mM
